According to a new report from Intel Market Research, the global Age-Related Macular Degeneration (AMD) Therapeutics market was valued at USD 7.81 billion in 2024 and is projected to reach USD 11.84 billion by 2034, growing at a CAGR of 6.3% during the forecast period (2025-2034). This growth trajectory reflects the increasing prevalence of retinal disorders among aging populations and...
Dutch 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek